| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 696.35M | 647.97M | 632.35M | 477.63M | 570.46M |
| Gross Profit | 284.76M | 43.93M | 103.46M | 18.00M | 50.52M |
| EBITDA | 83.10M | 52.75M | 94.96M | 35.52M | 39.26M |
| Net Income | 74.83M | 42.82M | 86.83M | 25.34M | 17.58M |
Balance Sheet | |||||
| Total Assets | 2.17B | 2.02B | 1.74B | 1.58B | 1.43B |
| Cash, Cash Equivalents and Short-Term Investments | 643.73M | 64.69M | 51.08M | 38.24M | 76.31M |
| Total Debt | 7.40M | 60.75M | 73.28M | 80.53M | 98.06M |
| Total Liabilities | 1.46B | 1.38B | 1.14B | 1.08B | 951.83M |
| Stockholders Equity | 707.98M | 635.88M | 596.10M | 503.12M | 475.66M |
Cash Flow | |||||
| Free Cash Flow | 210.21M | 111.50M | 7.51M | -139.05M | -57.53M |
| Operating Cash Flow | 210.21M | 111.50M | 7.51M | -31.80M | -56.30M |
| Investing Cash Flow | -149.17M | -96.56M | -53.13M | 47.02M | 23.09M |
| Financing Cash Flow | -65.14M | -21.24M | -5.29M | -19.83M | -10.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $563.79M | 6.59 | 11.10% | ― | 5.83% | -101.38% | |
71 Outperform | $2.38B | 5.55 | 20.87% | ― | 7.87% | -4.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $299.72M | 6.16 | 7.44% | 0.63% | -19.08% | 56.21% | |
62 Neutral | $324.05M | 11.18 | 7.67% | 3.59% | -0.09% | 83.67% | |
46 Neutral | $82.68M | 1.26 | 33.48% | ― | -66.75% | -50.53% | |
44 Neutral | $6.60M | -18.54 | -50.32% | ― | ― | 55.30% |
On February 2, 2026, Greenlight Capital Re, Ltd. announced that its General Counsel, Chief Compliance Officer and Corporate Secretary, David Sigmon, has given notice of his intention to resign effective May 1, 2026. The company stated that Sigmon’s departure is not due to any disagreement with management, the board, or company policies and operations, and he will remain in his current roles until his exit, suggesting an orderly transition for the insurer’s legal and compliance functions without immediate signs of internal turmoil.
The most recent analyst rating on (GLRE) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on Greenlight Capital Re stock, see the GLRE Stock Forecast page.